The Food and Drug Administration (FDA) has cleared the CustomFlex Artificial in the US, a prosthetic iris that is surgically implanted to treat adults and children whose iris is damaged or missing due to aniridia (a congenital condition) or other damages to the area.
Practitioners were invited to attend an exclusive early morning breakfast workshop at the Royal Society of Medicine in London on Friday February 23 to learn about the new Calecim Professional products.
Skincare developer AlumierMD has chosen aesthetic practitioner and founder of Perfect Skin Solutions, Dr Dev Patel, as its 2018 key opinion leader.
Skincare company NeoStrata has added the Skin Active Tri-Therapy Lifting Serum to its product portfolio.
Global pharmaceutical company Allergan has announced that Botox Cosmetic (onabotulinumtoxinA) has been approved by the US Food and Drug Administration for its third indication.
Aesthetic supplement manufacturer MINERVA Research Labs has announced 'positive results' for its latest clinical trial on GOLD COLLAGEN FORTE.
The Indiba Deep Beauty radiofrequency device will now be imported and distributed in the UK exclusively through Silver Street Associates (SSA).
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
Pharmaceutical company Allergan has announced the launch of Juvéderm VOLITE, the company’s first injectable treatment designed to improve skin quality.